Recent Patents on Cardiovascular Drug Discovery

Relation Between Sleep Quality and Physical Activity in Chronic Heart Failure Patients

Volume:6   Issue: 3
Pp: 161-167
Kazuhiro P. Izawa, Satoshi Watanabe, Koichiro Oka, Koji Hiraki, Yuji Morio, Yusuke Kasahara, Naoya Takeichi, Takae Tsukamoto, Naohiko Osada, Kazuto Omiya and Haruo Makuuchi
DOI: 10.2174/157489011797377004

Atrial Fibrillation Following Cardiac Surgery: Established and Emerging Strategies of Prevention

Volume:6   Issue: 3
Pp: 168-174
Nasir Shariff, Abdul Aleem, Larry E. Jacobs, Christopher Cutitta, Sultan M. Siddique, Matthew W. Martinez, Martin E. Matsumura and Ronald Freudenberger
DOI: 10.2174/157489011797377121

Novel Design and Synthesis of Modified Structure of Carvedilol

Volume:6   Issue: 3
Pp: 175-179
Mehrnoosh Hashemzadeh, Mohammad R. Movahed, Wade A. Russu, Ladan Soroush and Dine N. Hill
DOI: 10.2174/157489011797376988

Clinical Pharmacotherapy and Drug Development for Pulmonary Arterial Hypertension

Volume:6   Issue: 3
Pp: 180-188
Massimiliano Mule, Marilena Scarabelli, Davide Capodanno, Gian P. Ussia and Corrado Tamburino
DOI: 10.2174/157489011797377059

Growing Collateral Arteries On Demand

Volume:6   Issue: 3
Pp: 189-198
Charles C. Oh, Jason D. Klein, Raymond Q. Migrino and Kent L. Thornburg
DOI: 10.2174/157489011797377031

Human Embryonic and Induced Pluripotent Stem Cells in Cardiovascular Drug Discovery: Patents and Patented Uses

Volume:6   Issue: 3
Pp: 199-206
Christine Y. Ivashchenko
DOI: 10.2174/157489011797377077

P2Y12 Receptor Antagonists in Acute Coronary Syndrome: Clinical Implications of Pharmacologic and Pharmacogenetic Differences

Volume:6   Issue: 3
Pp: 207-214
Mukesh Singh, Sasikanth Adigopula, Niaz Ahmad, Rohit Arora and Sandeep Khosla
DOI: 10.2174/157489011797376960

Effects of Ranolazine on Cardiovascular System

Volume:6   Issue: 3
Pp: 215-221
Ivano Bonadei, Enrico Vizzardi, Filippo Quinzani, Barbara Piovanelli, Riccardo Rovetta, Antonio D'Aloia and Livio D. Cas
DOI: 10.2174/157489011797377103

Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark forthe Drug Development in the Context of the Cerebrovascular Diseases

Volume:6   Issue: 3
Pp: 222-241
Gjumrakch Aliev, Yi Li, Hector H. Palacios and Mark E. Obrenovich
DOI: 10.2174/157489011797376942

Patent Selections promotion: free to download

Volume:6   Issue: 3
Pp: 242-244
Bentham Science Publishers
DOI: 10.2174/157489011797377095